NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

ASH

Ashland Inc

Jul 15 • 04:00PM ET

51.06

Dollar change -1.38
Percentage change -2.63	%

Basic Materials • Specialty Chemicals • USA • NYSE

Peers: DD EMN PPG APD CE AVY ALB ECL IFF LYB

| Held by: IJH VTI VB VBR VXF MDY DFAT IJJ SCHA SPMD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.23	Insider Own	1.17%	Shs Outstand	45.69M	Perf Week	-5.39%
Market Cap	2.33B	Forward P/E	10.61	EPS next Y	4.81	Insider Trans	6.89%	Shs Float	45.16M	Perf Month	-1.18%
Enterprise Value	3.58B	PEG	-	EPS next Q	1.24	Inst Own	94.34%	Short Float	3.23%	Perf Quarter	1.09%
Income	-103.00M	P/S	1.20	EPS this Y	-13.88%	Inst Trans	-3.50%	Short Ratio	2.55	Perf Half Y	-25.91%
Sales	1.95B	P/B	0.91	EPS next Y	25.61%	ROA	-1.54%	Short Interest	1.46M	Perf YTD	-28.55%
Book/sh	56.00	P/C	9.68	EPS next 5Y	6.78%	ROE	-3.02%	52W High	98.44 -48.13%	Perf Year	-46.09%
Cash/sh	5.27	P/FCF	31.11	EPS past 3/5Y	-2.58% -15.86%	ROIC	-2.59%	52W Low	45.21 12.94%	Perf 3Y	-49.66%
Dividend Est.	1.70 (3.33%)	EV/EBITDA	8.60	Sales past 3/5Y	0.03% -3.25%	Gross Margin	25.85%	Volatility	2.69% 2.84%	Perf 5Y	-25.13%
Dividend TTM	1.63 (3.19%)	EV/Sales	1.84	EPS Y/Y TTM	-157.37%	Oper. Margin	7.23%	ATR (14)	1.60	Perf 10Y	-13.42%
Dividend Ex-Date	May 30, 2025	Quick Ratio	1.15	Sales Y/Y TTM	-7.63%	Profit Margin	-5.28%	RSI (14)	46.75	Recom	1.73
Dividend Gr. 3/5Y	11.17% 8.52%	Current Ratio	2.32	EPS Q/Q	-71.07%	SMA20	-0.93%	Beta	0.48	Target Price	68.00
Payout	46.75%	Debt/Eq	0.58	Sales Q/Q	-16.70%	SMA50	0.18%	Rel Volume	0.58	Prev Close	52.44
Employees	3200	LT Debt/Eq	0.55	Earnings	Apr 30 AMC	SMA200	-21.31%	Avg Volume	572.03K	Price	51.06
IPO	May 08, 1950	Option/Short	Yes / Yes	EPS/Sales Surpr.	-10.26% -4.70%	Trades		Volume	332,908	Change	-2.63%

Date	Action	Analyst	Rating Change	Price Target Change
May-01-25	Downgrade	Wells Fargo	Overweight → Equal Weight
Mar-26-25	Upgrade	JP Morgan	Neutral → Overweight	$68 → $71
Mar-05-25	Downgrade	Seaport Research Partners	Buy → Neutral
Aug-08-24	Upgrade	JP Morgan	Underweight → Neutral	$90 → $89
Apr-11-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$100 → $112
Mar-14-24	Upgrade	Jefferies	Hold → Buy	$100 → $126
Mar-01-24	Initiated	Wolfe Research	Outperform	$108
Jun-29-23	Downgrade	Evercore ISI	Outperform → In-line
Jun-26-23	Downgrade	BMO Capital Markets	Outperform → Market Perform	$109 → $90
Feb-02-23	Downgrade	JP Morgan	Neutral → Underweight	$104 → $105
Sep-12-22	Initiated	Credit Suisse	Outperform	$120
Jan-20-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$120 → $110
Nov-11-21	Downgrade	Monness Crespi & Hardt	Buy → Neutral
Oct-13-21	Initiated	Mizuho	Buy	$116
Jul-30-21	Upgrade	JP Morgan	Underweight → Neutral	$90
Jun-18-21	Initiated	Stifel	Buy	$118
May-04-21	Downgrade	JP Morgan	Neutral → Underweight	$88 → $89
Mar-15-21	Resumed	Credit Suisse	Outperform	$103
Feb-05-21	Reiterated	Monness Crespi & Hardt	Buy	$88 → $100
Sep-22-20	Initiated	Evercore ISI	In-line

Show Previous Ratings

Jul-14-25 05:00PM	Operations leadership changes announced at Ashland (GlobeNewswire)
Jul-09-25 09:29AM	Ashland Advances Strategic $60M Manufacturing Network Optimization (Zacks)
Jul-08-25 05:00PM	Ashland advances strategic $60MM network optimization (GlobeNewswire)
Jun-05-25 09:05AM	Are Options Traders Betting on a Big Move in Ashland Stock? (Zacks)
May-30-25 11:31AM	Why Is Ashland (ASH) Up 3.9% Since Last Earnings Report? (Zacks)
05:00PM	Loading…
May-28-25 05:00PM	Ashland hosts Innovation Day for analysts and investors (GlobeNewswire)
May-14-25 01:37PM	Tech Breakthrough Could Upend the $650 Billion Plastics Market (Oilprice.com)
May-08-25 06:45AM	Valvoline Inc. Announces Kevin Willis as Chief Financial Officer (PR Newswire)
May-06-25 05:15PM	Ashland board authorizes quarterly dividend (GlobeNewswire)
08:49AM	Ashland's Q2 Earnings and Revenues Miss Estimates, Down Y/Y (Zacks)
May-05-25 05:00PM	Ashland announces executive leadership changes (GlobeNewswire)
May-02-25 03:12AM	Ashland Inc (ASH) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
02:54AM	Q2 2025 Ashland Inc Earnings Call (Thomson Reuters StreetEvents)
May-01-25 07:48PM	Ashland, Inc. (ASH) Q2 2025 Earnings Call Transcript (Seeking Alpha) -9.85%
Apr-30-25 07:30PM	Ashland (ASH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
06:50PM	Loading…
06:50PM	Ashland (ASH) Lags Q2 Earnings and Revenue Estimates (Zacks)
05:47PM	Ashland: Fiscal Q2 Earnings Snapshot (Associated Press Finance)
05:01PM	Ashland reports second quarter fiscal 2025 results and revises full-year outlook (GlobeNewswire)
Apr-24-25 10:01AM	Earnings Preview: Quaker Chemical (KWR) Q1 Earnings Expected to Decline (Zacks)
08:15AM	Blachem (BCPC) Lags Q1 Earnings Estimates (Zacks)
Apr-23-25 10:01AM	Earnings Preview: Ashland (ASH) Q2 Earnings Expected to Decline (Zacks)
Apr-22-25 11:02AM	Ashland Inc. (ASH): Among the Dividend Paying Stocks Insiders Are Buying (Insider Monkey)
Apr-17-25 11:16PM	Ashland Inc. (ASH): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025 (Insider Monkey)
06:30AM	Ashland sets date for second-quarter fiscal 2025 earnings release and conference call webcast (GlobeNewswire)
Apr-11-25 10:07AM	ClearBridge Mid Cap Strategy Sold Ashland (ASH) in Q1 Amid Sluggish End Markets (Insider Monkey)
Apr-10-25 09:02AM	Daqo (DQ) Soars 6.1%: Is Further Upside Left in the Stock? (Zacks) -6.11%
05:50AM	ClearBridge Mid Cap Strategy Q1 2025 Commentary (Seeking Alpha)
Apr-03-25 12:04PM	Ashland Wraps Up Expansion of Pharmaceutical Plant in Brazil (Zacks) -8.28%
Apr-01-25 06:59AM	Ashland expands pharmaceutical plant for Aquarius tablet coatings and commissions new microbial protection capability in Brazil, demonstrating strategy to globalize, innovate, and invest (GlobeNewswire)
Mar-28-25 05:03PM	Is Ashland Inc. (ASH) About to Explode? (Insider Monkey)
06:59AM	Loading…
06:59AM	Ashland to host 2025 Innovation Day for analysts and investors (GlobeNewswire)
Mar-26-25 10:21PM	Tracking Leon Cooperman's Omega Advisors Portfolio - Q4 2024 Update (SeekingAlpha)
Mar-17-25 07:00AM	Ashland completes sale of Avoca business to Mane (GlobeNewswire)
Mar-13-25 02:41PM	Are Options Traders Betting on a Big Move in Ashland (ASH) Stock? (Zacks)
Feb-22-25 10:04AM	Ashland Inc. (ASH): Among the Most Expensive Stocks Insiders Are Buying Recently (Insider Monkey)
Feb-13-25 08:14AM	Ashland (ASH) Slid due to Competitive Pressures (Insider Monkey)
Jan-31-25 02:17AM	Ashland Inc (ASH) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Jan-30-25 03:10AM	Q1 2025 Ashland Inc Earnings Call (Thomson Reuters StreetEvents)
Jan-28-25 05:23PM	Ashland: Fiscal Q1 Earnings Snapshot (Associated Press Finance) -9.82%
05:01PM	Ashland reports financial results for first quarter fiscal 20251, reiterates outlook for full-year fiscal 2025 (GlobeNewswire)
07:08AM	What To Expect From Ashland Inc (ASH) Q1 2025 Earnings (GuruFocus.com)
Jan-27-25 07:04AM	Earnings To Watch: Ashland Inc (ASH) Reports Q1 2025 Result (GuruFocus.com)
Jan-20-25 05:00PM	Ashland board authorizes quarterly dividend (GlobeNewswire)
01:09PM	Why Is Lee Cooperman Bullish On Ashland Inc. (ASH) Now? (Insider Monkey)
Jan-16-25 07:09AM	Bear of the Day: Ashland Inc (ASH) (Zacks)
Jan-14-25 07:00AM	Ashland sets date for first-quarter fiscal 2025 earnings release and conference call webcast (GlobeNewswire)
Dec-23-24 05:01PM	Ashland signs definitive agreement to sell Avoca business to Mane (GlobeNewswire)
Dec-16-24 04:15PM	Ingevity elects Kevin Willis to its board of directors (Business Wire)
Dec-09-24 05:01PM	Ashland rings opening bell at NYSE recognizes 100-year anniversary (GlobeNewswire)
06:30AM	Ashland celebrates solvers, recognizes 100 years of innovation by planting trees to restore local ecosystems and support sustainable sourcing (GlobeNewswire)
Nov-21-24 01:00AM	Ashland Global Holdings Debt Challenges: Implications for Growth and Market Competitiveness (TipRanks)
Nov-14-24 07:00AM	Ashland board authorizes quarterly dividend (GlobeNewswire)
Nov-08-24 07:00AM	Ashland to host live 2024 strategy update event for analysts and investors (GlobeNewswire)
02:16AM	Ashland Inc (ASH) Q4 2024 Earnings Call Highlights: Strong Margin Recovery Amid Global Challenges (GuruFocus.com)
Nov-06-24 07:15PM	Ashland (ASH) Q4 Earnings Lag Estimates (Zacks) -7.64%
06:27PM	Ashland: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
05:00PM	Ashland reports financial results for fourth-quarter fiscal 20241, issues outlook for full-year fiscal 2025, provides portfolio optimization update and announces strategy update event (GlobeNewswire)
07:09AM	Ashland Inc (ASH) Q4 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-05-24 09:15AM	Unveiling Ashland (ASH) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks)
07:40AM	Ashland Inc (ASH) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Oct-31-24 12:22PM	Weak Demand Pulled Down Ashland (ASH) in Q3 (Insider Monkey)
Oct-28-24 05:00PM	Ashland sets date for fourth-quarter fiscal 2024 earnings release and conference call webcast (GlobeNewswire)
Oct-09-24 10:40AM	Ashland (ASH) Slid on Weaker Demand (Insider Monkey)
Oct-07-24 07:31AM	Is Ashland Global Holdings Inc. (ASH) the Top Pick in Leon Coopermans Stock Portfolio? (Insider Monkey)
Sep-19-24 10:06AM	D.A. Davidson Acts as Exclusive Financial Advisor to Turnspire Capital Partners for Debt Financing in Support of Turnspire's Acquisition of Pharmachem (Business Wire)
Sep-16-24 07:00AM	Ashland accelerates application of super wetting technology, commercializes superior wetting agent for corn, soy, wheat, watermelon, other produce and florals (GlobeNewswire)
Sep-03-24 07:00AM	Turnspire Capital Partners Completes Acquisition of Pharmachem from Ashland (Business Wire)
07:00AM	Pharmachem Innovations Launches as a Leading Independent Provider of Nutraceuticals Products and Solutions (Business Wire)
07:00AM	Ashland completes sale of nutraceuticals business (GlobeNewswire)
Sep-01-24 10:04PM	Ashland Inc. (ASH): Strong Performance with 20.64% Upside Potential in Specialty Chemicals (Insider Monkey)
Aug-28-24 08:04PM	10 Best Specialty Chemical Stocks To Buy Now (Insider Monkey)
Aug-25-24 01:53PM	Valvoline Can Be a Slick Addition to Your Portfolio (The Wall Street Journal)
Aug-23-24 09:40AM	Here's Why Ashland (ASH) is a Strong Value Stock (Zacks)
Aug-09-24 05:01PM	Ashland board authorizes quarterly dividend (GlobeNewswire)
Aug-07-24 09:40AM	Why Ashland (ASH) is a Top Value Stock for the Long-Term (Zacks) -9.57%
06:55AM	Ashland's (ASH) Earnings Beat Estimates in Q3, Sales Lag (Zacks)
Aug-06-24 05:31PM	Ashland: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
05:01PM	Ashland reports financial results1 for third quarter fiscal 2024, issues outlook for fourth quarter and full-year fiscal 2024 (GlobeNewswire)
Aug-05-24 09:40AM	Are Basic Materials Stocks Lagging ASHLAND INC (ASH) This Year? (Zacks) -5.03%
Jul-25-24 04:39PM	Ashland Inc. (ASH): Why Does Ricky Sandler Recommend This Stock Right Now? (Insider Monkey)
Jul-17-24 07:00AM	Ashland sets date for fiscal 2024 third-quarter earnings release and conference call webcast (GlobeNewswire)
Jun-24-24 07:00AM	Ashland announces strategy, mergers and acquisitions, and portfolio management leader (GlobeNewswire)
Jun-18-24 07:00AM	Ashland achieves certification by Fair Wage Network (GlobeNewswire)
Jun-04-24 08:00AM	Ashland announces Life Sciences business leader (GlobeNewswire)
May-30-24 11:31AM	Ashland (ASH) Up 4% Since Last Earnings Report: Can It Continue? (Zacks)
May-17-24 09:25AM	3 Future Breakout Stocks That Wall Street Is Already Loving (InvestorPlace)
May-09-24 11:03AM	Ashland (ASH) to Divest Nutraceuticals Business to Turnspire (Zacks)
May-08-24 05:01PM	Ashland Board appoints Ashish K. Kulkarni as new director (GlobeNewswire)
09:50AM	Ashland (ASH) is a Top-Ranked Momentum Stock: Should You Buy? (Zacks)
May-07-24 05:01PM	Ashland board authorizes quarterly dividend (GlobeNewswire)
07:00AM	Turnspire Capital Partners to Acquire Ashland Nutraceuticals Business (Business Wire)
06:59AM	Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners (GlobeNewswire)
May-06-24 09:40AM	Is Ashland Inc. (ASH) Stock Outpacing Its Basic Materials Peers This Year? (Zacks)
May-02-24 04:02PM	Ashland Inc. (NYSE:ASH) Q2 2024 Earnings Call Transcript (Insider Monkey)
08:45AM	Ashland's (ASH) Earnings & Revenues Surpass Estimates in Q2 (Zacks)
03:17AM	Ashland Inc (ASH) Q2 2024 Earnings Call Transcript Highlights: Navigating Market Challenges and ... (GuruFocus.com)
May-01-24 04:52PM	Why Ashland Stock Fell Today (Motley Fool)
Apr-30-24 09:53PM	ASH Stock Earnings: Ashland Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace)
06:32PM	Ashland Inc (ASH) Q2 Fiscal 2024 Earnings: Surpasses EPS Estimates, Faces Revenue Decline (GuruFocus.com)
05:13PM	Ashland: Fiscal Q2 Earnings Snapshot (Associated Press Finance)

Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MINICUCCI JAMES P.	SVP and GM, Personal Care	May 08 '25	Option Exercise	49.99	1,395	69,736	3,149	May 12 04:30 PM
Kulkarni Ashish K	Director	May 06 '25	Option Exercise	0.00	1,032	0	1,032	May 08 04:30 PM
NOVO GUILLERMO	Chair of the Board and CEO	Jan 31 '25	Buy	64.24	31,294	2,010,327	31,294	Feb 03 04:30 PM
Assis Alessandra Faccin	SVP and GM, Life Sciences	Jan 31 '25	Buy	64.00	3,150	201,600	3,150	Feb 03 04:30 PM
Harrison Suzan F.	Director	Jan 23 '25	Option Exercise	0.00	1,931	0	1,931	Jan 24 04:30 PM
BONI ERIC N	VP, Finance & Prinpl Acctg Off	Dec 05 '24	Sale	78.07	451	35,210	14,182	Dec 09 05:15 PM
BONI ERIC N	VP, Finance & Prinpl Acctg Off	Dec 04 '24	Option Exercise	59.95	451	27,037	14,633	Dec 05 05:00 PM
BONI ERIC N	Officer	Dec 05 '24	Proposed Sale	78.07	451	35,210		Dec 05 09:53 AM
LAMPKIN ROBIN E.	SVP, Gen Counsel and Secrty.	Nov 19 '24	Option Exercise	76.39	418	31,931	3,641	Nov 20 04:30 PM
LAMPKIN ROBIN E.	SVP, Gen Counsel and Secrty.	Nov 19 '24	Sale	75.54	162	12,237	3,354	Nov 20 04:30 PM
MUSA OSAMA M	SVP and CTO	Nov 19 '24	Option Exercise	76.39	1,878	143,460	27,288	Nov 20 04:30 PM
BOSTAPH KARL R.	Senior VP Operations	Nov 19 '24	Option Exercise	76.39	418	31,931	7,165	Nov 20 04:30 PM
Drury Eileen	SVP and Chief HRO	Nov 19 '24	Option Exercise	76.39	911	69,591	6,606	Nov 20 04:30 PM
BONI ERIC N	VP, Finance & Prinpl Acctg Off	Nov 19 '24	Option Exercise	76.39	450	34,376	14,312	Nov 20 04:30 PM
WILLIS J KEVIN	SVP and CFO	Nov 19 '24	Option Exercise	76.39	3,486	266,296	234,324	Nov 20 04:30 PM
NOVO GUILLERMO	Chair of the Board and CEO	Nov 19 '24	Option Exercise	76.39	11,096	847,623	131,382	Nov 20 04:30 PM
WILLIS J KEVIN	SVP and CFO	Nov 18 '24	Option Exercise	77.03	3,860	297,336	231,649	Nov 19 05:06 PM
NOVO GUILLERMO	Chair of the Board and CEO	Nov 18 '24	Option Exercise	77.03	12,639	973,582	122,778	Nov 19 04:42 PM
Drury Eileen	SVP and Chief HRO	Nov 18 '24	Option Exercise	77.03	1,101	84,810	5,956	Nov 19 04:42 PM
LAMPKIN ROBIN E.	SVP, Gen Counsel and Secrty.	Nov 18 '24	Option Exercise	77.03	486	37,437	3,293	Nov 19 04:41 PM
MUSA OSAMA M	SVP and CTO	Nov 18 '24	Option Exercise	77.03	2,081	160,299	25,751	Nov 19 04:41 PM
BOSTAPH KARL R.	Senior VP Operations	Nov 18 '24	Option Exercise	77.03	638	49,145	6,888	Nov 19 04:40 PM
BONI ERIC N	VP, Finance & Prinpl Acctg Off	Nov 18 '24	Option Exercise	77.03	510	39,285	13,931	Nov 19 04:39 PM
LAMPKIN ROBIN E.	Officer	Nov 19 '24	Proposed Sale	75.54	162	12,237		Nov 19 10:12 AM
MUSA OSAMA M	SVP and CTO	Nov 14 '24	Option Exercise	78.05	2,031	158,520	24,776	Nov 18 05:36 PM
BOSTAPH KARL R.	Senior VP Operations	Nov 14 '24	Option Exercise	78.05	1,054	82,265	6,728	Nov 18 05:35 PM
Drury Eileen	SVP and Chief HRO	Nov 14 '24	Option Exercise	78.05	1,258	98,187	5,711	Nov 18 05:34 PM
WILLIS J KEVIN	SVP and CFO	Nov 14 '24	Option Exercise	78.05	3,771	294,327	230,497	Nov 18 05:34 PM
NOVO GUILLERMO	Chair of the Board and CEO	Nov 14 '24	Option Exercise	78.05	8,865	691,913	116,649	Nov 18 05:33 PM
LAMPKIN ROBIN E.	SVP, Gen Counsel and Secrty.	Nov 14 '24	Option Exercise	78.05	1,238	96,626	4,121	Nov 18 05:33 PM
LAMPKIN ROBIN E.	SVP, Gen Counsel and Secrty.	Nov 15 '24	Sale	77.90	868	67,617	2,883	Nov 18 05:33 PM
MINICUCCI JAMES P.	SVP and GM, Personal Care	Nov 14 '24	Option Exercise	78.05	1,190	92,880	2,126	Nov 18 05:32 PM
BONI ERIC N	VP, Finance & Prinpl Acctg Off	Nov 14 '24	Option Exercise	78.05	602	46,986	13,674	Nov 18 05:31 PM
LAMPKIN ROBIN E.	Officer	Nov 15 '24	Proposed Sale	77.90	868	67,617		Nov 15 01:19 PM
WILLIS J KEVIN	SVP and CFO	Sep 03 '24	Option Exercise	59.95	5,487	328,946	22,539	Sep 05 04:30 PM
WILLIS J KEVIN	SVP and CFO	Sep 04 '24	Sale	87.88	5,487	482,198	17,052	Sep 05 04:30 PM
WILLIS J KEVIN	Officer	Sep 04 '24	Proposed Sale	87.88	5,487	482,198		Sep 04 11:14 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ASH

Ashland Inc

Upgrade your FINVIZ experience